GCAL® - Plasma and serum calprotectin in routine use
15. Dec 2022 |
4 min read
Clinical value: Plasma and serum calprotectin
Calprotectin in blood shows significant diagnostic value in various infectious and inflammatory conditions, and the biomarker is gaining more and more interest. GCAL® - Gentian's plasma and serum calprotectin assay is today in routine use at various hospitals and clinical chemistry laboratories across Europe where the assay is used in the fields of:
Routine use of GCAL® - Plasma and serum calprotectin
Two institutions using GCAL® in routine at their institutions are Labor Berlin – Charité Vivantes GmbH in Germany and the Assistance Publique-Hôpitaux de Paris (APHP Centre) in France.
Labor Berlin experienced an increasing demand for plasma and serum calprotectin testing, and therefore wanted to implement an automated solution for plasma and serum calprotectin. APHP was searching for additional biomarkers to complement routine biomarkers like CRP, IL-6 during the 1st COVID-19 wave, looking for a biomarker that would better stratify severity and prognosis1.
The answer to demand for an automated plasma and serum calprotectin
Labor Berlin – Charité Vivantes GmbH has a broad spectrum of use of calprotectin at their associated hospitals. The test is open to order for all their clinical departments, and requests span from multiple clinical areas, including neurology, paediatrics, rheumatology, dermatology and ICU.
From part of clinical studies to routine inflammation marker
At the Assistance Publique-Hôpitaux de Paris (APHP Centre) the interest in calprotectin came with a need for new biomarkers during the 1st COVID-19 wave. After seeing the strong association of calprotectin with COVID-19 severity and prognosis, the biomarker is now also perceived as a new informative biomarker of residual inflammation in autoimmune diseases and a valuable biomarker in clinical practice.
Webinar: Calprotectin, a new routine inflammation biomarker, APHP Centre
This webinar is especially noteworthy for laboratory professionals and clinicians who are already familiar with plasma and serum calprotectin, and that are curious to learn more from the experience of routine customer of the Gentian Calprotectin GCAL®. At APHP Centre the biomarker is perceived as an informative biomarker of residual inflammation in autoimmune diseases and a valuable biomarker in clinical practice.
GCAL® is certified by TüV SÜD as complying with the European In-Vitro Diagnostic Regulation (IVDR), EU 2017/746, and we are now working on the final steps of updating the products' labels and documents.
Contact us for further information
Explore GCAL® in your laboratory - fill out the form or send an email to email@example.com for more information about the product and prices.